We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

8 hedge funds and large institutions have $4.46M invested in Eterna Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

78% more capital invested

Capital invested by funds: $2.51M → $4.46M (+$1.95M)

14% more funds holding

Funds holding: 7 → 8 (+1)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
+$1.2M
2
CA
Callahan Advisors
Texas
+$120K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$120K
4
Renaissance Technologies
Renaissance Technologies
New York
+$120K

Top Sellers

Rank Fund Capital Flow
1
MHP
Manatuck Hill Partners
Connecticut
-$95K
2
TRCT
Tower Research Capital (TRC)
New York
-$7K
3
IIC
Integrated Investment Consultants
Michigan
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$2.76M +$1.2M +10 +83%
EAM
2
Eagle Asset Management
Florida
$766K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$214K +$120K +1 +100%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$180K – – –
CA
5
Callahan Advisors
Texas
$160K +$120K +1 New
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$128K +$120K +1 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$115K – – –
Goldman Sachs
8
Goldman Sachs
New York
$112K – – –
BIT
9
BlackRock Institutional Trust
California
$22K – – –
BFA
10
BlackRock Fund Advisors
California
$3K – – –
UBS Group
11
UBS Group
Switzerland
$3K – – –
Barclays
12
Barclays
United Kingdom
$1K – – –
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Manulife (Manufacturers Life Insurance)
14
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
Morgan Stanley
15
Morgan Stanley
New York
$1K – – –
MHP
16
Manatuck Hill Partners
Connecticut
– -$95K -1 Closed
IIC
17
Integrated Investment Consultants
Michigan
– -$1K – –
TRCT
18
Tower Research Capital (TRC)
New York
– -$7K – –

ERNA Hedge Fund Activity: Q4 2016 in Review

8 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2016, worth a combined $4.46M — up 78% from $2.51M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ERNA positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was AWM Investment Company, adding an estimated $1.2M. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $95K sold.

  • 8 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2016, up from 7 in Q3 2016.
  • Funds reported $4.46M of Eterna Therapeutics stock for Q4 2016, up 78% quarter-over-quarter.
  • 2 funds opened new Eterna Therapeutics positions in Q4 2016 and 1 closed out, a net change of +1 holder.
  • The largest Eterna Therapeutics buyer in Q4 2016 was AWM Investment Company, an estimated $1.2M added.
  • The largest Eterna Therapeutics seller in Q4 2016 was Manatuck Hill Partners, an estimated $95K sold.

Based on aggregated 13F filings for Q4 2016.